Neuromyelitis Optica Spectrum Disorder Treatment—Current and Future Prospects

Neuromyelitis Optica Spectrum Disorder Treatment—Current and Future Prospects

Neuromyelitis optica (NMO) is an immune-mediated demyelinative disorder of the central nervous system affecting mainly the optical nerves and the spinal cord. The recurrent course of the disease, with exacerbations and incomplete remissions, causes accumulating disability, which has a profound impac...

Full description

Bibliographic Details
Main Authors: Marta Waliszewska-Prosół, Justyna Chojdak-Łukasiewicz, Sławomir Budrewicz, Anna Pokryszko-Dragan
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:International Journal of Molecular Sciences
Subjects:
neuromyelitis optica spectrum disorder
demyelinating diseases
aquaporin 4
autoimmune humoral response
treatment
Online Access:https://www.mdpi.com/1422-0067/22/6/2801

Internet

https://www.mdpi.com/1422-0067/22/6/2801

Similar Items